Strict COVID-19 measures have had a negative impact on a programme aimed at providing HIV prevention medicine and gender based violence counselling services for vulnerable girls and young women. Adele Baleta reports.
It seems HIV and TB are falling by the wayside in the drive to stop the spread of COVID-19. Where we can we must minimise the harm to the HIV and TB response, and we need to see the opportunity to address all three diseases together, writes Erica Penfold.
Around the turn of the century developing countries fought for and won safeguards to promote access to medicines in international trade law. These safeguards are now being heralded by lawmakers around the world as critical legal mechanisms that nations can and must use in the fight against COVID-19, writes Catherine Tomlinson.
Last year KwaZulu-Natal celebrated three districts’ achievement of the UNAIDS 90-90-90 targets. But celebrations may have been premature, as new data shows that no district in KZN in fact met the targets. Spotlight visited one of the districts to investigate.
The so-called “London patient” is still HIV-free, 30 months after receiving a bone marrow transplant to treat blood cancer, according to a study published on Tuesday in the Lancet HIV journal.
Thanks to community-led monitoring in South Africa, we now have the data to back up the stories we have all heard about – early morning queues that last all day long when clinics fail to open on time and then also close early, writes Anele Yawa and Lotti Rutter.
Over the last decade there have been significant decreases in the rates of new HIV infections, HIV-related deaths, and mother-to-child transmission (MTCT) in South Africa. Yet, there are still staggering gaps between different subsets of the population.